Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics, Inc. is a healthcare company focused on medical technology for the treatment of dentofacial abnormalities, obstructive sleep apnea, and snoring in adults. The company’s core offering, The Vivos Method, is a non-invasive, non-surgical, and non-pharmaceutical treatment approach that uses a multidisciplinary model for these conditions. It also provides the VivoScore Program, which combines screening with at-home sleep testing for both adults and children. Vivos Therapeutics markets its appliances, related treatments, and services to licensed professionals, with a primary focus on general dentists in the United States and Canada. Founded in 2016 and based in Littleton, Colorado, the company previously operated under the name Vivos BioTechnologies, Inc. before adopting its current name in March 2018. Its common stock trades on the NASDAQ exchange under the symbol VVOS.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-VVOS
|
$0.23
|
39.8% Upside
|
Undervalued
|
$2.12 1,197.0% Upside
|
Not available
|
Bargain
|
Weak
|
0.0%
|
November 18, 2026
|
0.2x
|
3.283 M
|
14.948 M
|
73.6%
|
94.9%
|
-22.3
|
74.7%
|
